AstraZeneca Profit Falls on Generic Competition

Feb. 6 (Bloomberg) -- AstraZeneca said fourth-quarter profit fell as sales of its best-selling medicines and growth in emerging markets failed to compensate for increasing generic competition. Anna Edwards reports on Bloomberg Television's "Countdown." (Source: Bloomberg)
Why China Invested in 'T.H.U.N.D.E.R. Agents'
45:34 - Batman Film Franchise Executive Producer Michael Uslan discusses the international financing of films. He speaks on "Bloomberg Markets." (Source: Bloomberg)
  • Is the Biotech Backlash Warranted?
  • Airbnb CEO: We Want to Be Regulated
  • What Challenges Is the Airline Industry Facing?